Lok Sabha Question No. 2689 (UNSTARRED), answered on 2025-08-05
Subject: PLI  Schemes for Medical Devices
Ministry: COMMERCE AND INDUSTRY
Asked by: Shri Eatala Rajender, Smt. D K Aruna, Shri Chamala Kiran Kumar Reddy

## GOVERNMENT OF INDIA MINISTRY OF COMMERCE & INDUSTRY DEPARTMENT FOR PROMOTION OF INDUSTRY AND INTERNAL TRADE

## LOK SABHA

UNSTARRED QUESTION NO. 2689.

TO BE ANSWERED ON TUESDAY, THE 05 TH  AUGUST, 2025.

## PLI SCHEMES FOR MEDICAL DEVICES

## 2689.  SHRI CHAMALA KIRAN KUMAR REDDY:

SMT. D K ARUNA:

SHRI EATALA RAJENDER:

## Will the Minister of COMMERCE AND INDUSTRY be pleased to state: वाणिज्य एवं उद्योग मंत्री

- (a) whether the Government has rolled out PLI schemes for 14 key sectors, which included  bulk  drugs,  medical  devices  and  pharma,  with  an  eye  on  boosting production,  generating  jobs  and  boosting  exports  by  incentivising  domestic manufacturing;
- (b) if  so,  the  details  thereof  along  with  guidelines  issued  and  implemented  and thereafter revised in this regard;
- (c) the number of products covered along with the financial outlay for the purpose;
- (d) the  number  of  applications  invited  and  approved  by  the  Government  in  the Pharmaceuticals Sector under the said scheme for 14 key sectors;
- (e) the details of investment reported till June, 2025; and
- (f) the  details  of  incentives  that  have  been  disbursed  under  the  PLI  schemes including  Large-Scale  Electronics  Manufacturing  (LSEM),  IT  hardware,  bulk drugs,  medical  devices,  pharmaceuticals,  telecom  and  networking  products, food processing, white goods automobiles and auto components and drones and drone components and the present status thereof?

## ANSWER

## वाणिज्य एवं उद्योग मंत्रालय में राज्य मंत्री ( श्री णिणिन प्रसाद ) THE MINISTER OF STATE IN THE MINISTRY OF COMMERCE & INDUSTRY (SHRI JITIN PRASADA)

- (a): Keeping in view India's vision of becoming 'Atmanirbhar', Production Linked Incentive (PLI) Schemes for 14 key sectors were announced with an outlay of Rs. 1.97 lakh crore to enhance India's Manufacturing capabilities and Exports.

The  14  sectors  are:  (i)  Mobile  Manufacturing  and  Specified  Electronic Components, (ii) Critical Key Starting Materials/Drug Intermediaries & Active Pharmaceutical Ingredients, (iii) Manufacturing of Medical Devices

(iv)  Automobiles  and  Auto  Components,  (v)  Pharmaceuticals  Drugs,  (vi) Specialty Steel, (vii) Telecom  &  Networking  Products, (viii) Electronic/ Technology Products, (ix) White Goods (ACs and LEDs), (x) Food Products, (xi) Textile Products: MMF segment and technical textiles, (xii) High efficiency solar  PV  modules,  (xiii)  Advanced  Chemistry  Cell  (ACC)  Battery,  and  (xiv) Drones and Drone Components.

The purpose of the PLI Schemes is to attract investments in key sectors and cutting-edge technology; ensure efficiency and bring economies of size and scale in the manufacturing sector and make Indian companies and manufacturers  globally  competitive.  These  schemes  have  the  potential  of significantly boosting production, employment and economic growth over the next five years or so.

Actual investment of Rs. 1.76 lakh crore have been realized till March 2025 across 14 sectors, which has resulted in incremental production/sales of over Rs. 16.5 lakh crore and employment generation of over 12 lakhs (direct and indirect). PLI Schemes have transformed India's exports basket from traditional commodities to high value-added products such as electronics & telecommunication goods, processed food products etc. PLI Schemes have witnessed exports surpassing Rs. 6 lakh crore, with significant contributions from sectors such as Large-Scale Electronics Manufacturing, Pharmaceuticals, Food Processing, and Telecom & Networking products.

- (b): PLI Schemes for all 14 Sectors have been notified along with guidelines by the concerned  Ministries/  Departments  after  due  approval.  The  details  of  the scheme  guidelines  and  the  subsequent  revisions  along  with  the  target segments/  eligible  products  are  available  in  the official  website  of the implementing Ministries/ Departments. Approved products under PLI Schemes have  been  strategically selected to align with national goals, increase production capacity, enhance global competitiveness and promote exports in critical sectors such as electronics, renewable energy, pharmaceuticals, textiles etc.,  ensuring  their  alignment  with  the  objectives  of  Make  in  India  and Atmanirbhar Bharat.
- (c) to (e): There  are  three  PLI  schemes  being  implemented  by  the  Department  of pharmaceuticals namely, PLI Scheme for Pharmaceutical Drugs, PLI Scheme for  promotion  of  domestic  manufacturing  of  critical  Key  Starting  Materials (KSMs)/  Drug  Intermediates  (DIs)  and  Active  Pharmaceutical  Ingredients (APIs) in India (PLI Scheme for Bulk Drugs) and PLI Scheme for promoting domestic manufacturing of medical devices. PLI Scheme for Pharmaceutical Drugs with an approved outlay of Rs. 15,000 crores has witnessed investment of  Rs.  37,306  crore  from  55  approved  applicants.  On  the  other  hand,  PLI Scheme  for  Bulk  Drugs  with  an  approved  outlay  of  Rs.  6,940  crores  has witnessed investment of Rs. 4,570 crores from 48 approved applicants. Further, PLI Scheme for Medical Devices with an approved outlay of Rs. 3,420 crores has resulted in an investment of Rs. 1,150 crores from 32 approved applicants.

The impact of PLI Schemes has been significant across various sectors in India. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports. The pharmaceuticals sector has witnessed cumulative sales of Rs. 2.66 lakh crore which includes exports of Rs. 1.70 lakh crore achieved in the first three years of the scheme. The scheme has contributed to India becoming a net exporter of bulk drugs (2280 cr.) from net importer (-1930 cr.) as was the case in FY 2021-22. It has also resulted in significant reduction in gap between the domestic manufacturing capacity and demand of critical drugs.

Under  the  PLI  Scheme  for  medical  devices,  21  projects  have  started manufacturing of 54 unique medical devices, which include high end devices such  as  Linear  Accelerator  (LINAC),  MRI,  CT-Scan,  Heart  Valve,  Stent, Dialyzer Machine, C-Arm, Cath Lab, Mammograph, MRI Coils, etc. These Highend medical devices were imported earlier and are now being manufacture in India.   The production of mobiles in value terms has increased by around 146% from  INR  2,13,773  Cr  in  2020-21  to  INR  5,25,000  crore  in  2024-25  as  per industry association and DGCIS. During the same period, exports of mobile phones in value terms has increased by around 775% from INR 22,870 crore in 2020-21 to INR 2,00,000 crore in 2024-25.

The PLI Scheme for White Goods is aimed at developing a robust component ecosystem for the Air Conditioners and LED Lights industry in India, with the goal of making the country an integral part of global supply chains. A unique feature  of  the  scheme  is  that  it  incentivizes  only  the  manufacturing  of components and sub- assemblies, not finished products. Following its launch, India  has  begun  local  production  of  key  components  such  as  compressors, copper  tubes,  heat  exchangers,  motors,  and  control  assemblies  for  air conditioners, as well as LED chip packaging, drivers, engines, light management systems, and metallized films for capacitors in the LED segment. This  shift  is  significantly  reducing  import  dependency  and  strengthening domestic manufacturing capabilities.

- (f): Cumulative incentive amount of Rs. 21,689 crore have been disbursed as on 31.07.2025 under PLI Scheme for 12 sectors, namely Large Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals,  Telecom  &  Networking  Products,  Food  Processing,  White Goods, Drones & Drone Components, Specialty Steel, Textile products and Automobiles & Auto components.

********